Drug Eluting Balloon Market - Global Forecast to 2026, by Product Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon, and Others), by End User (Hospitals, CATH Laboratories, Ambulatory Surgery Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026
- Report code : CMI42459 |
- Industry :
Medical Devices
- Published On : Jan 2019 |
- Pages : 168 Pages |
- Format :
Global Drug Eluting Balloon Market – A Novel Approach for Coronary Heart Disease
Drug eluting balloon plays a major role in modern healthcare, as it homogenously delivers medication to the vessel and prevents neointimal hyperplasia.
The global drug eluting balloon market size was valued at US$ 420 million in 2017, and is expected to exhibit a CAGR of 8.1% over the forecast period (2018 – 2026).
Figure 1. Global Drug Eluting Balloon Market Value (US$ Mn), by Region, 2017
Source: Coherent Market Insights Analysis (2018)
Increasing prevalence of coronary artery disease and diabetes is expected to propel growth of the drug eluting balloon market
Drug eluting balloon is an angioplasty balloon, which plays a vital role in treatment of coronary artery disease. High prevalence of coronary artery disease is expected to propel demand for angioplasty and other treatments, which in turn is expected to drive the market growth. According to the World Health Organization (WHO), around 3.8 million men and 4.4 million women die, annually from coronary heart disease worldwide. Moreover, the number of deaths from age 15 to 59 is around 1332 thousands and for above 60 years of age is around 5825 thousands.
Diabetes can damage blood vessels and nerves associated with heart and can lead to cardiovascular disease. Therefore, increasing prevalence of diabetes is expected to propel growth of the drug eluting balloon market over the forecast period. For instance, according to WHO’s, October 2018 report, around 1.6 million deaths are registered due to diabetes globally. Moreover, the global prevalence of diabetes among adults over 18 years of age is estimated to increase from 4.7% to 8.5% from 1980 to 2014. The adoption of drug eluting balloon is majorly preferred by surgeons due to its effective treatment of peripheral artery and coronary artery diseases.
However, adverse effects such as coronary artery lesion and lumen enlargement are expected to hinder the market growth. For instance, in May 2017, Abbott recalled three balloon catheters due to difficulty in removing balloon sheath, which caused 19 reports of injury and 1 death.
Figure 2. Global Drug Eluting Balloon Market Share (%), by Product, 2018 and 2026
Source: Coherent Market Insights Analysis (2018)
Increasing adoption of drug eluting balloon in North America is expected to bolster the market growth
North America holds dominant position in the global drug eluting balloon market, owing to high prevalence of obesity, which further develops cardiovascular and coronary artery diseases. In October 2017, according to the National Center for Health Statistics (NCHS), estimated the prevalence of obesity in adults was around 39.8% and in youth 18.5% in the year 2015 -16 in the U.S. Increasing prevalence of cardiovascular diseases developed from tobacco and smoking in the region is also expected to boost the market growth.
Similarly, according to WHO, in March 2018, around 7 million death were recorded due to tobacco use in which round 890,000 were due to second hand smoke globally.
Moreover, increasing geriatric population that is prone to cardiovascular diseases is expected to propel demand for angioplasty, which in turn is expected to boost the market growth. For instance, according to CDC, in May 2016, around 19% of the population in the U.S. is projected to fall in the geriatric category by 2030. Moreover, in the U.S., around 40 million individuals above 65 years and above are affected by cardio vascular diseases.
Key Players
Major players operating in the global drug eluting balloon market include, Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc., and Biotronik.
Drug eluting balloons are angioplasty balloons that are coated with an anti-proliferative drug, which is eluted in vessel walls during the inflation of balloon, usually at nominal pressure with a specific minimal inflation time. The active substance coated on the drug eluting balloon should be lipophilic in nature to have a high absorption rate through the vessel wall. Mostly paclitaxel is used as active ingredient due to its high pharmacokinetic transfer rate into the vessel wall and it is actively used in drug eluting balloons in the U.S. market and has been already approved for use in Europe.
Market Dynamics
Increasing prevalence of coronary artery diseases is a major factor driving drug eluting balloon market growth. According to American College of Cardiology, June 2017, around 17.92 million cardiovascular deaths were registered in 2015 worldwide. Moreover, key players in the market are focused on adopting acquisition strategies in order to gain access to innovative products and expand their product offerings in the potential markets. For instance, in April 2010, Medtronic acquired Invatec and affiliated companies. Invatec launched 4 new drug eluting balloons in Europe in 2009 including In.Pact Amphirion, In.Pact Admiral, In.Pact Pacific, and In.Pact Falcon. Medtronic is focused on enhancing its international presence by expanding treatment option for patients with cardiovascular disease.
Key features of the study:
- This report provides in-depth analysis of the drug eluting balloon market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global drug eluting balloon market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc., and Biotronik.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global drug eluting balloon market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the drug eluting balloon market
Detailed Segmentation:
- Global Drug Eluting Balloon Market, By Product Type:
- Coronary Drug Eluting Balloon
- Peripheral Drug Eluting Balloon
- Others
- Global Drug Eluting Balloon Market, By End User:
- Hospitals
- CATH Laboratories
- Ambulatory Surgical Centers
- Others
- Global Drug Eluting Balloon Market, By Geography:
- North America
- By Product Type:
- Coronary Drug Eluting Balloon
- Peripheral Drug Eluting Balloon
- Others
- By End User:
- Hospitals
- CATH Laboratories
- Ambulatory Surgery Centers
- Others
- By Country:
- U.S.
- Canada
- Latin America
- By Product Type:
- Coronary Drug Eluting Balloon
- Peripheral Drug Eluting Balloon
- Others
- By End User:
- Hospitals
- CATH Laboratories
- Ambulatory Surgery Centers
- Others
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type:
- Coronary Drug Eluting Balloon
- Peripheral Drug Eluting Balloon
- Others
- By End User:
- Hospitals
- CATH Laboratories
- Ambulatory Surgery Centers
- Others
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type:
- Coronary Drug Eluting Balloon
- Peripheral Drug Eluting Balloon
- Others
- By End User:
- Hospitals
- CATH Laboratories
- Ambulatory Surgery Centers
- Others
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type:
- Coronary Drug Eluting Balloon
- Peripheral Drug Eluting Balloon
- Others
- By End User:
- Hospitals
- CATH Laboratories
- Ambulatory Surgery Centers
- Others
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type:
- Coronary Drug Eluting Balloon
- Peripheral Drug Eluting Balloon
- Others
- By End User:
- Hospitals
- CATH Laboratories
- Ambulatory Surgery Centers
- Others
- By Country:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Medtronic *
- Company Overview
- Product Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Cook Medical
- B. Braun Melsungen AG
- Koninklijke Philips N.V.
- Opto Circuits (India) Limited
- Terumo Corporation
- Surmodics, Inc.
- Biotronik
“*” marked represents similar segmentation in other categories in the respective section
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Impact Analysis
- Key Highlights
- PEST Analysis
- PORTER’s Analysis
- Mergers and Acquisitions
- Epidemiology
- Global Drug Eluting Balloon Market, By Product Type, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Coronary Drug Eluting Balloon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Peripheral Drug Eluting Balloon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Global Drug Eluting Balloon Market, By End User, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- CATH Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Ambulatory Surgery Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Global Drug Eluting Balloon Market, By Region, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profiles
- Medtronic *
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Becton, Dickinson and Company
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Boston Scientific Corporation
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cook Medical
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- B. Braun Melsungen AG
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Koninklijke Philips N.V.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Opto Circuits (India) Limited
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Terumo Corporation
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Surmodics, Inc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Biotronik
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- Section
- References
- Research Methodology
- About Us and Sales Contact
*Browse 35 market data tables and 28 figures on "Drug Eluting Balloon Market - Global forecast to 2026”.
Related Insights :
Share
Choose License Type
"How Can I Help You" ?
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Key Benefits
Custom Research Solution
Talk to our research consultant to design an exclusive report as per your research needs.
Customer Fulfilment
We aim to fulfil client's research demands with tailored research solutions.
Quick Turnaround Time Reports
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
360-degree Approach
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
Assured Quality
We strive to provide most accurate and reliable research findings in our research reports.